• Please log in or register to access this feature.

ORIGINAL PAPER

You have free access to this content

Association Between Antihypertensive Medication Adherence and Visit-to-Visit Variability of Blood Pressure

  1. Paul Muntner PhD1,
  2. Emily B. Levitan ScD1,
  3. Cara Joyce MPH2,
  4. Elizabeth Holt PhD3,
  5. Devin Mann MD4,
  6. Suzanne Oparil MD1,
  7. Marie Krousel-Wood MD3,5

Article first published online: 28 NOV 2012

DOI: 10.1111/jch.12037

Issue

The Journal of Clinical Hypertension

The Journal of Clinical Hypertension

Volume 15, Issue 2, pages 112–117, February 2013

Additional Information

How to Cite

Muntner, P., Levitan, E. B., Joyce, C., Holt, E., Mann, D., Oparil, S. and Krousel-Wood, M. (2013), Association Between Antihypertensive Medication Adherence and Visit-to-Visit Variability of Blood Pressure. The Journal of Clinical Hypertension, 15: 112–117. doi: 10.1111/jch.12037

Author Information

  1. 1

    From the Departments of Epidemiology and Medicine, University of Alabama at Birmingham, Birmingham, AL;

  2. 2

    Department of Biostatistics, Tulane University, New Orleans, LA;

  3. 3

    Center for Health Research, Ochsner Clinic Foundation, New Orleans, LA;

  4. 4

    Department of Medicine, Boston University, Boston, MA;

  5. 5

    Departments of Medicine and Epidemiology, Tulane University, New Orleans, LA

*Paul Muntner, PhD, Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Suite 230J, Birmingham, AL 35294 E-mail: pmuntner@uab.edu

Publication History

  1. Issue published online: 22 JAN 2013
  2. Article first published online: 28 NOV 2012
  3. Manuscript received: July 23, 2012; revised: September 9, 2012; accepted: September 20, 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (83K)

References

  • 1
    Muntner P, Shimbo D, Tonelli M, et al.The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension.2011;57:160–166.
  • 2
    Rothwell PM, Howard SC, Dolan E, et al.Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet.2010;375:895–905.
  • 3
    Verdecchia P, Borgioni C, Ciucci A, et al.Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit.1996;1:3–11.
  • 4
    Muntner P, Joyce C, Levitan EB, et al.Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical practice. J Hypertens.2011;29:2332–2338.
  • 5
    Howard SC, Rothwell PM. Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke. Cerebrovasc Dis.2009;28:331–340.
  • 6
    Krakoff LR. Fluctuation: does blood pressure variability matter. Circulation.2012;126:525–527.
  • 7
    Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol.2004;19:357–362.
  • 8
    Krousel-Wood MA, Muntner P, Islam T, et al.Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am.2009;93:753–769.
  • 9
    DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care.2004;42:200–209.
  • 10
    Muntner P, Judd SE, Krousel-Wood M, et al.Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis.2010;56:447–457.
  • 11
    Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich).2008;10:348–354.
    Direct Link:
  • 12
    Krousel-Wood M, Islam T, Webber LS, et al.New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care.2009;15:59–66.
  • 13
    Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol.1997;50:105–116.
  • 14
    Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med.2000;132:926–930.
  • 15
    Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care orgnizations. Am J Manag Care.2006;12:239–245.
  • 16
    Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet.2010;375:938–948.
  • 17
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med.2005;353:487–497.
  • 18
    World Health Orgainzation. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
  • 19
    Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet.2010;375:906–915.
  • 20
    Dolan E, O’Brien E. Blood pressure variability: clarity for clinical practice. Hypertension.2010;56:179–181.
  • 21
    Grove JS, Reed DM, Yano K, Hwang LJ. Variability in systolic blood pressure – a risk factor for coronary heart disease?Am J Epidemiol.1997;145:771–776.
  • 22
    Mancia G. Prognostic value of long-term blood pressure variability: the evidence is growing. Hypertension.2011;57:141–143.
View Full Article with Supporting Information (HTML) Get PDF (83K)